Neuroone Medical Technologies (NMTC) Debt Ratio (2010 - 2024)

Neuroone Medical Technologies' (NMTC) quarterly Debt Ratio came in at 0.02 in Q1 2024, up 41.7% on a QoQ basis from 0.02 in Q3 2023.

Neuroone Medical Technologies (NMTC) Debt Ratio (2010 - 2024) Analysis & Trends

Neuroone Medical Technologies (NMTC) has 9 years of Debt Ratio data on file, last reported at 0.02 in Q1 2024.

Quarterly Debt Ratio changed N/A year-over-year to 0.02 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.02 (changed N/A YoY) and the FY2023 annual result came in at 0.02, changed N/A from the prior year.
Debt Ratio climbed to 0.02 in Q1 2024, from 0.02 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.02 in Q1 2024 to a low of 0.02 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	0.30
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	0.31
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	0.30
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	0.04
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	0.28
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	0.18
10	Neuroone Medical Technologies	19.89 Mn	17.84 Mn	1.18 Mn	-

Download Data